Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin
BACKGROUND: Caspofungin is an echinocandin class antifungal medication that is commonly used empirically in immunocompromised patients at high risk for invasive fungal disease.
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2012/957973 |
id |
doaj-f8b7c4e526224fccb165d2307bd315cf |
---|---|
record_format |
Article |
spelling |
doaj-f8b7c4e526224fccb165d2307bd315cf2021-07-02T02:49:33ZengHindawi LimitedCanadian Journal of Infectious Diseases and Medical Microbiology1712-95322012-01-0123417918210.1155/2012/957973Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving CaspofunginShaun K Morris0Upton D Allen1Sumit Gupta2Susan E Richardson3Division of Infectious Diseases, Toronto, Ontario, CanadaDivision of Infectious Diseases, Toronto, Ontario, CanadaDivision of Haematology and Oncology, Department of Pediatrics, Toronto, Ontario, CanadaDivision of Microbiology, The Hospital for Sick Children, Toronto, Ontario, CanadaBACKGROUND: Caspofungin is an echinocandin class antifungal medication that is commonly used empirically in immunocompromised patients at high risk for invasive fungal disease.http://dx.doi.org/10.1155/2012/957973 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Shaun K Morris Upton D Allen Sumit Gupta Susan E Richardson |
spellingShingle |
Shaun K Morris Upton D Allen Sumit Gupta Susan E Richardson Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin Canadian Journal of Infectious Diseases and Medical Microbiology |
author_facet |
Shaun K Morris Upton D Allen Sumit Gupta Susan E Richardson |
author_sort |
Shaun K Morris |
title |
Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin |
title_short |
Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin |
title_full |
Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin |
title_fullStr |
Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin |
title_full_unstemmed |
Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin |
title_sort |
breakthrough filamentous fungal infections in pediatric hematopoetic stem cell transplant and oncology patients receiving caspofungin |
publisher |
Hindawi Limited |
series |
Canadian Journal of Infectious Diseases and Medical Microbiology |
issn |
1712-9532 |
publishDate |
2012-01-01 |
description |
BACKGROUND: Caspofungin is an echinocandin class antifungal medication that is commonly used empirically in immunocompromised patients at high risk for invasive fungal disease. |
url |
http://dx.doi.org/10.1155/2012/957973 |
work_keys_str_mv |
AT shaunkmorris breakthroughfilamentousfungalinfectionsinpediatrichematopoeticstemcelltransplantandoncologypatientsreceivingcaspofungin AT uptondallen breakthroughfilamentousfungalinfectionsinpediatrichematopoeticstemcelltransplantandoncologypatientsreceivingcaspofungin AT sumitgupta breakthroughfilamentousfungalinfectionsinpediatrichematopoeticstemcelltransplantandoncologypatientsreceivingcaspofungin AT susanerichardson breakthroughfilamentousfungalinfectionsinpediatrichematopoeticstemcelltransplantandoncologypatientsreceivingcaspofungin |
_version_ |
1721342752796442624 |